Singular Genomics Systems, Inc. (OMIC)
USD 20.01
(0.0%)
USD 20.01
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -94.82 Million USD | -7.42% |
| 2022 | -88.27 Million USD | 10.74% |
| 2021 | -98.88 Million USD | -245.01% |
| 2020 | -28.66 Million USD | -132.26% |
| 2019 | -12.34 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -21.25 Million USD | 15.07% |
| 2024 Q1 | -25.02 Million USD | -7.63% |
| 2023 Q3 | -22.36 Million USD | 12.58% |
| 2023 FY | -94.82 Million USD | -7.42% |
| 2023 Q4 | -23.24 Million USD | -3.98% |
| 2023 Q2 | -25.57 Million USD | -15.49% |
| 2023 Q1 | -22.14 Million USD | -12.58% |
| 2022 Q2 | -23.72 Million USD | -7.86% |
| 2022 Q1 | -21.99 Million USD | -11.3% |
| 2022 FY | -88.27 Million USD | 10.74% |
| 2022 Q4 | -19.67 Million USD | 14.04% |
| 2022 Q3 | -22.88 Million USD | 3.52% |
| 2021 FY | -98.88 Million USD | -245.01% |
| 2021 Q4 | -19.75 Million USD | -12.2% |
| 2021 Q3 | -17.61 Million USD | 53.01% |
| 2021 Q1 | -23.92 Million USD | -202.34% |
| 2021 Q2 | -37.47 Million USD | -56.68% |
| 2020 FY | -28.66 Million USD | -132.26% |
| 2020 Q4 | -7.91 Million USD | 0.26% |
| 2020 Q3 | -7.93 Million USD | -15.86% |
| 2020 Q2 | -6.84 Million USD | -30.34% |
| 2020 Q1 | -5.25 Million USD | 0.0% |
| 2019 FY | -12.34 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | -49.74% |
| AngioDynamics, Inc. | -184.34 Million USD | 48.565% |
| AtriCure, Inc. | -30.43 Million USD | -211.518% |
| Avinger, Inc. | -18.32 Million USD | -417.576% |
| Azenta, Inc. | -14.25 Million USD | -565.077% |
| BioLife Solutions, Inc. | -66.42 Million USD | -42.743% |
| The Cooper Companies, Inc. | 294.2 Million USD | 132.23% |
| Daxor Corporation | 280.64 Thousand USD | 33887.058% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | -523.898% |
| Femasys Inc. | -14.24 Million USD | -565.538% |
| GlucoTrack, Inc. | -7.09 Million USD | -1236.057% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -2676.574% |
| Hologic, Inc. | 789.5 Million USD | 112.01% |
| ICU Medical, Inc. | -29.65 Million USD | -219.744% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 105.274% |
| KORU Medical Systems, Inc. | -13.74 Million USD | -590.049% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 414.964% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -1322.991% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -1322.991% |
| Masimo Corporation | 81.5 Million USD | 216.344% |
| Microbot Medical Inc. | -10.74 Million USD | -782.868% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 915.627% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 200.433% |
| Nephros, Inc. | -1.57 Million USD | -5920.317% |
| NovoCure Limited | -207.04 Million USD | 54.203% |
| NEXGEL, Inc. | -3.15 Million USD | -2903.484% |
| NEXGEL, Inc. | -3.15 Million USD | -2903.484% |
| OraSure Technologies, Inc. | 53.65 Million USD | 276.722% |
| Pro-Dex, Inc. | 2.12 Million USD | 4557.922% |
| Pulse Biosciences, Inc. | -42.21 Million USD | -124.639% |
| Predictive Oncology Inc. | -13.98 Million USD | -578.062% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -3112.738% |
| QuidelOrtho Corporation | -10.1 Million USD | -838.812% |
| Repligen Corporation | 41.57 Million USD | 328.059% |
| Sanara MedTech Inc. | -4.3 Million USD | -2103.478% |
| STAAR Surgical Company | 21.34 Million USD | 544.184% |
| Sharps Technology, Inc. | -9.84 Million USD | -863.458% |
| Utah Medical Products, Inc. | 16.63 Million USD | 670.003% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 28.167% |
| Jin Medical International Ltd. | 2.87 Million USD | 3394.386% |